International Journal of Nursing Practice

Cover image for Vol. 22 Issue 5

Edited By: Lin Perry

Impact Factor: 0.98

ISI Journal Citation Reports © Ranking: 2015: 64/114 (Nursing (Social Science)); 67/116 (Nursing (Science))

Online ISSN: 1440-172X

Author Guidelines

Aims and Scope
The International Journal of Nursing Practice publishes original scholarly work that advances the international understanding and development of nursing and midwifery both as professions and as academic disciplines.
Papers in the following fields will be considered:

  • Original research papers
  • Knowledge transfer/ implementation science/ quality improvement papers
  • Literature reviews
  • Research methodology papers
  • Discussion papers

All papers must have a sound scientific, theoretical or philosophical base. Authors should bear in mind the international readership of the Journal and ensure their text and its content are understandable and have relevance for readers world-wide. Papers up to a maximum of 4,000 words will be considered.

For information on the processes and policies of the journal see below:
The Review Process. General points in preparing your manuscript. Parts of the manuscript. Submission. Post acceptance publication process. Copyright. Online Open. Author material archive policy. Note to NIH grantees.

For author guidelines for specific types of papers see:


Those submitting papers to the journal must accept responsibility for preparing papers to a level suitable for review. This preparation should include subjecting the paper to critique by colleagues and others by “workshopping” and revising the paper prior to submission. Manuscripts should be written in a clear, concise, direct style, and so that they are intelligible to the professional reader who is not a specialist in the particular field. The acceptance criteria for all papers are the quality of the research, the significance of its contribution to nursing, the quality of the work as a whole, relevance to our international readership and the clarity of presentation as judged by the Editor-in-Chief, considering but not bound by the advice of referees and associate editors.

All manuscripts are screened by the Editor-in-Chief and Editor to ensure they meet the journal’s criteria and, if published, would be likely to be read and cited by the Journal’s readership and would have potential to contribute to the advancement of nursing knowledge, policy and practice. There is no process of appeal for papers declined at this stage.
Manuscripts are checked for their adherence to International Journal of Nursing Practice author guidelines and for similarity to other publications using iThenticate software. Manuscripts not conforming to the author guidelines and/ or showing substantial similarity to other published material are returned to the author to be rectified or are declined.
Papers sent to review will only be those that are determined to meet the appropriate quality and relevance requirements.

Manuscripts sent to review will be reviewed by at least two people. This will include one peer reviewer using a double-blind system, and either a second blinded reviewer or an Editor/Editor-in-Chief. When the reviews are returned, the Editor-in-Chief or Editor reads the paper again and identifies the next step: whether any further modifications are required, or if the paper can be accepted or should be declined. If further revision is required, the resubmitted revised version will be returned to the same reviewers unless they prefer not to see it again. Similar to other journals, our policy is that the reviewers advise the Editor and Editor in Chief but it is the latter who makes the final decision reserves the right to decline any material for publication.
The Editors retain the right to modify the style of a manuscript to eliminate ambiguity and repetition and improve communication between author and reader but any major changes will be agreed with the author(s), who will view the final version when they are asked to check the final page proofs.

Reviewer Conflicts of Interest
Reviewers are asked to declare any conflict of interest they are aware of. Conflicts of interest would include: if they work or have worked in the same institution and collaborated with the authors, if they own stock in a particular company, or if they have a personal relationship with the authors. Such conflicts of interest will not automatically disqualify the individual from acting as a reviewer; however reviewers are obligated to provide the Editor with this information so that they may make a determination on the suitability of the proposed reviewer.

Editorial conflicts of interest
Members of the Editorial Board including the Editor-in-Chief are welcome to publish in the journal. If a submission authored by a member of the editorial team or board is received, to ensure unbiased and independent handling of such papers through review the manuscript will be processed by editorial team members with no relationship to the author other than their journal role; i.e. no history of collaboration or affiliation in common.
In instances of the above a statement noting the exceptional arrangement will be included in the published paper.


Please read the Author Guidelines carefully prior to submission, including the section on copyright. To ensure fast peer review and publication, manuscripts that do not adhere to the following instructions are returned to the corresponding author for technical revision before consideration and peer review.

Please note that by submitting your manuscript to the International Journal of Nursing Practice you are indicating that the content has not been published or submitted for publication elsewhere (except as a brief abstract in the proceedings of a scientific meeting or symposium). This journal uses iThenticate plagiarism software and all manuscripts are screened on submission.

Once you have prepared your submission in accordance with the journal's guidelines, it can be submitted online at

Authors who require assistance should contact the Editorial Assistant via the Editorial Office:

Detail for each type of submission are available here:

Preparing Your Manuscript

Manuscripts should follow the style of the Vancouver agreement detailed in the International Committee of Medical Journal Editors' revised 'Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publications', as presented at

Authors should bear in mind the international readership of the Journal and ensure their text and its content are understandable and have relevance for readers world-wide. Colloquial language should be avoided and any terms that are essential but have specific local meanings (such as UK Trusts, Australian Local Health Districts) should be explained. The relevance of findings and any implications should be considered for the wider readership, not just the location of origin.

The journal uses UK spelling and authors should therefore follow the latest edition of the Concise Oxford Dictionary.

All measurements must be given in SI units.

Abbreviations should be used sparingly and only where they ease the reader’s task by reducing repetition of long, technical terms. Initially use the word in full, followed by the abbreviation in parentheses. Thereafter use the abbreviation.

At the first mention of a chemical substance, give the generic name only. Trade names should not be used.

Drugs should be referred to by their generic names, rather than brand names.

Submissions should be prepared in word-processing software and should be saved in .doc or .rtf formats. The text file should be set with top, bottom and side margins of 25mm.

  • Indent new paragraphs
  • Do not use the carriage return (enter) at the end of lines within a paragraph
  • Turn the hyphenation option off
  • Specify any special characters used to represent non-keyboard characters
  • Take care not to use l (ell) for 1 (one), O (capital o) for 0 (zero) or ß (German esszett) for b (Greek beta)
  • Use a tab, not spaces, to separate data points in tables
  • If you use a table editor function, ensure that each data point is contained within a unique cell; i.e. do not use carriage returns within cells.

Parts of the Manuscript
The manuscript should be submitted in separate files: title page; main text file; figures. Additional supporting/ supplementary material for website publication only may also be uploaded as a separate, additional, file.

Information can be located at:
Title page. Authorship. Main text file. Abstract. Summary statement.Key words. Statistical reporting. Ethical considerations. Acknowledgements. Disclosure.References. Tables.Figures.Supplementary information (online only).

Title page
The title page should contain
(i) a short informative title that contains the major key words. A short running title (less than 40 characters, including spaces) should also be provided. The title should not contain abbreviations or specify the country of origin
(ii) the full names of the authors and a maximum of 3 qualifications per author, to include RN/RM where appropriate
(iii) the author's institutional affiliations, at which the work was carried out (maximum of 3 per author), and job titles
(iv) the full postal and email address, plus telephone number, of the author to whom correspondence about the manuscript should be sent
(v) acknowledgements
(vi) authorship statement confirming that all listed authors meet the authorship criteria and that all authors are in agreement with the content of the manuscript. The present address of any author, if different from that where the work was carried out, should be supplied in a footnote.

Authorship Criteria
Each author should have participated sufficiently in the work to take public responsibility for the content. Authorship credits should be based on substantial contributions to: (i) conception and design, or analysis and interpretation of data; (ii) drafting the article or revising it critically for important intellectual content; and (iii) final approval of the version to be published.
Conditions (i), (ii) and (iii) must all be met by all named authors.

Main text file
As papers are double-blind peer reviewed the main text file should not include any information that might identify the authors. The main text of the manuscript should be presented in the following order:
(i) abstract, summary statement and key words
(ii) text, acknowledgements and disclosure
(iii) references
(iv) tables (each table complete with title and footnotes)
(v) figure legends
(vi) appendices.
Figures and supporting/ supplementary information should be submitted as separate files. Additional supporting/ supplementary material for website publication only may also be uploaded as a separate file and should be referred to in the text in numbered form as Supplementary 1, Supplementary 2, etc. Footnotes to the text are not allowed and any such material should be incorporated into the text as parenthetical matter.

i)Abstract, summary statements and key words
All articles must have a brief abstract that states in 200 words or fewer the purpose, basic procedures, main findings and principal conclusions of the study. The abstract should contain headings such as Aim, Methods, Results (or Findings), Conclusion. See guidance for individual types of papers for more details. The Abstract should not contain abbreviations, detailed statistics or references.

Summary statement
Include a summary statement giving up to 3 succinct bullet points under each of the three headings:
What is already known about this topic? (include key points and/ or knowledge gaps)
What this paper adds: (research findings/ key new information)
The implications of this paper: (how findings influence or can be used to change policy/practice/research/education).

Key words
A maximum of 10 key words should be supplied below the abstract, in alphabetical order, and should be taken from those recommended by the Index Medicus Medical Subject Headings (MeSH) browser list ( Please include Nursing. Ensure these words are used in the title, Abstract and Summary Statement to aid retrieval of the paper from searches.

Authors should use subheadings to divide the sections of their manuscript: Introduction, Methods, Results, Discussion, Conclusion, Acknowledgements, Disclosure, References, Tables. Headings should be modified as appropriate for Discussion papers. Detail of content for each type of submission are available here:

Statistical reporting
Statistical reporting starts with clear and concise statement of study aims and objectives/ research questions, with explanation of any technical terminology. Indicate which study objectives are primary, secondary or other objectives (if applicable).

Study Design
Describe the main features of the study design and specify the outcome variables.

State clearly whether the study was designed as exploratory or confirmatory; recognize that hypothesis generating and hypothesis testing analyses are different and be clear on which the paper describes:
Exploratory Analysis: The study objectives may not always lead to pre-determined hypotheses and tests. The data analysis may include data exploration and require a flexible approach that allows for changes in response to accumulating results.
Confirmatory Analysis: The key hypothesis is pre-defined, follows from the primary study objective/ research question, and is tested. The study is adequately controlled. Firm evidence in support of the claims should suffice to answer the primary objectives. The results should be robust (in contrast to being sensitive to outliers or missing values) and reliable.

Population and sample:
Describe the target population of the study and also the eligible, evaluable, per protocol, and intention to treat populations (if applicable). The subjects in the study should mirror the target population as closely as possible, as appropriate to study design.

Identify the type of sample and the selection mechanism of the sample (e.g. random sample, convenience sample, any stratification used); the pool from which the sample was drawn and any pre-specified inclusion and exclusion criteria; if appropriate, the assignment mechanism (randomized, partially randomized, non-randomized etc.) to different arms or treatments, and any blinding techniques used.

If a convenience sample was used or the subjects were not randomly assigned to treatments or arms, justify these choices; if appropriate, explain for which population the sample is representative and to what extent the results are generalizable. Fully acknowledge the limitations of the study design and methods.

Sample Size and Power:
Describe the expected sample size, and the (primary) outcome variable(s), distributional assumptions, parameters, the effect size, the choice of significance levels and power (if appropriate), upon which this sample size was based. Studies should be powered on the main objective and its appropriate analysis.

State the method of sample size calculation clearly and justify the assumptions made.

Use study/sampling/data flow charts to describe complicated sampling/dropout/study designs where useful and possible.

Data collection
Describe the method of data collection and its specifics (e.g. number of questions and range of response scores of questionnaires, meaning of scores).

Justify choice of the selected tool or instrument, state whether the tool/ instrument has been shown to be valid and reliable; supply key statistics where appropriate and list references that document evidence in support of their psychometric properties. Demonstrate that measuring instruments or questionnaires are reliable and valid in the study population.

If using a newly developed or "modified" tool, provide reasons and address the validity and reliability issues.

If using a previously developed/ published tool, address the issue of copyright.

Statistical Analysis
Describe the statistical analysis clearly. If the analysis methods were specified prior to the statistical analysis (e.g. in a protocol), this should be stated here. If some of the analysis methods were selected after looking at the data, this should be mentioned as well.

Specify the software and the version of software used in the analysis.

Describe the main features of the performed statistical analysis clearly (e.g. confidence interval, including degree of confidence, hypothesis tests, including null/ alternative hypotheses, level of significance, particular test and test statistic); explain the statistical methodology that was used, and provide suitable references to the statistical literature if the statistical method is not elementary and/or its description in the paper is not self-contained.

Use and reference literature reviews for sophisticated techniques such as factor analysis.

Describe in detail the procedures that were applied to handle missing values and data, any outliers (supply the definition for an outlier), multiple hypothesis testing and adjustments for multiplicity, quantifying the type I error rate (e.g. Bonferroni, Holm, Hochberg, etc. adjusted p-values), or any other irregularities to which the statistical analysis could be sensitive.

Address issues such as multi-collinearity in multiple regression and multiple comparisons in ANOVA. Use multivariate techniques if appropriate for answering the research question (for example, instead of reporting multiple correlations).

Ensure appropriate choice of parametric/ non-parametric statistics. Use data transformations if needed, and justify and describe them.

Describe the model assumptions checks that were performed (e.g. test of normality or other distributional assumptions under the null hypothesis of any hypothesis test carried out, goodness-of-fit tests, tests for homoscedasticity of residuals, graphical plots or representations).

If necessary, consult a statistician during the design of the study and to review statistical analyses, presentation and interpretation of results.

Ethical Considerations
Principles for Publication of Research Involving Human Subjects:
Manuscripts must contain a statement to the effect that all human studies have been reviewed by the appropriate local ethics review process, such as an ethics committee and have therefore been performed in accordance with the ethical standards laid down in an appropriate version of the Declaration of Helsinki (as revised in Brazil 2013), available at a specifically ethical review process is not locally deemed necessary for the type of study reported, this should be explained.

It should be stated clearly in the text that all persons gave their informed consent prior to their inclusion in the study, or the rationale provided for any deviation from this. Details that might disclose the identity of the subjects under the study should be omitted. It is not necessary to name the specific research ethics committee or supply the reference number, although all trials should supply the relevant trial registration number.

Carefully explain how the results address each study objective. Illustrate the main characteristics of the key variables in suitable tables and/or graphical presentations but do not duplicate information in the text. Make sure that the style and presentation of the results and tables are of sufficiently high quality.

Report summary statistics, result summaries, or the quantities associated with a p-value in tables. When p-values associated with statistical tests are tabulated, indicate the particular test statistic, the degree of freedom, sample size, and the precise p-value (e.g. "p=0.003" or "p 0.001"). In exploratory studies, confidence intervals are preferred over hypothesis tests, yet p-values may be calculated and utilized to flag specific differences of interest and highlight differences worth further examination in future studies.

For the presentation of tables, figures, graphs, diagrams and images see the Tables and Figures sections. Make sure that the format of the cell entries and data results (including use of decimal places) are consistent throughout the table and manuscript.

Use appropriate measures of central tendency and spread (e.g. not means for highly skewed data) as summary statistics.

Summarize the response rates and the number (percentage) of missing and non-missing values in the appropriate tables or results.

Report effects of variables in measures that are clinically relevant, distinguishing between statistical and clinical significance. Do not conclude that a non-significant result ‘proves’ the null hypothesis.

Indicate adjustments of p-values together with the results.

Include a brief summary of the model assumption checks used to validate the assumptions of the presented models.

Make sure that results derive from the data and analyses described and address the study objectives/ question; that conclusions arise from the results.

Provide an interpretation of the analyses/ results of the study, highlighting new findings and contributions. Consider findings in the light of prior knowledge presented in the Introduction. Do not introduce new topics / content at this stage; if it is important in light of findings, it should feature in the Introduction.

Describe possible limitations to the study, such as the limits of generalizability of the study, how the sample does/ does not adequately represent the population of interest. Identify any potential sampling bias (such as comparability to control group, representativeness of sample population), violations of inclusion/exclusion criteria, irregularities or deviation from the planned study conduct that may have occurred. These may include limitations that impair the statistical analysis and/or affect the interpretation of the results.

Indicate the observed values for the variables and/or statistics whose values were estimated prior to the study in order to estimate the sample size and state any discrepancies between these estimated and observed values. Explain how these discrepancies may impact the power of a hypothesis test.

Address (if appropriate) the sensitivity of the analyses results, including p-values, regarding missing values, missing data imputation used, multiplicity issues, and any violations of model assumptions, how outliers were treated if likely to over-influence the analysis.

Without repeating what has been said before, summarize the new knowledge / contribution of the study for nursing. Elaborate the implications of this for nursing practice, management and policy, education and future research.

The source of financial grants and other funding should be acknowledged, including a frank declaration of the authors’ industrial links and affiliations. The contribution of colleagues or institutions should also be acknowledged. Thanks to anonymous reviewers are not allowed.

Disclosure: Authors must declare any financial support or relationships that may pose conflict of interest. Report all sources of revenue related to this work and the topic of this work paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work should also be listed here. If there is any question, you should report the relationship.

For grants you have received for work outside the submitted work, you should disclose support from non-public sector entities within the area of research. Public funding sources, such as government agencies, charitable foundations or academic institutions, need not be disclosed.

If the authors have no conflict of interest to report, add the statement that, ‘The authors declare no conflict of interest’.

iii) References
The use of a tool such as EndNote or Reference Manager for reference management and formatting is recommended. EndNote reference styles can be searched for; download the style for the International Journal of Nursing Practice at
The Vancouver system of referencing is required. In the text, references should be cited using superscript Arabic numerals in the order in which they appear. If cited only in tables or figure legends, number them according to the first identification of the table or figure in the text. In the reference list, the references should be numbered and listed in order of appearance in the text.

Cite the names of all authors when there are six or fewer; when more than seven list the first three followed by et al.

Reference to unpublished data and personal communications should not appear in the list but should be cited in the text only (e.g. Smith A, 2000, unpublished data).

References should be listed in the following form:

Journal articles
1. Meretoja R, Numminen O, Isoaho H, Leino-Kilpi H. Nurse competence between three generational nurse cohorts: A cross-sectional study. International Journal of Nursing Practice 2015; 21: 350–358.

Online articles not yet published in an issue
An online article that has not yet been published in an issue (therefore has no volume, issue or page numbers) can be cited by its Digital Object Identifier (DOI). The DOI will remain valid and allow an article to be tracked even after its allocation to an issue.

2. Chen Y-M, Li Y-P, Yen M-L. Predictors of regular exercise among older residents of long-term care institutions. International Journal of Nursing Practice 2015. doi: 10.1111/ijn.12401.

Books and Chapters in Books
3. Gordon S, Buchanan J, Bretherton T. Safety in Numbers: Nurse-to-Patient Ratios and the Future of Health Care. New York, NY, USA: Cornell University Press, 2008.

4. Hoel H, Salin D. Organisational antecedents of workplace bullying. In: Einarsen S, Hoel H, Zapf D, Cooper CL (eds). Bullying and Harassment in the Workplace, 2nd edn. Boca Raton, FL, USA: CRC Press, 2003; 203–218.

Electronic Material
5. World Health Organization. Strategic directions for strengthening nursing and midwifery services 2011–2015. Geneva: World Health Organization, 2010. Available from URL: Accessed 20 February 2013.

iv) Tables
Tables should be self-contained and complement, but not duplicate, information contained in the text. Tables should be numbered consecutively in Arabic numerals. A comprehensive but concise legend should appear above the table. Tables should be double-spaced and vertical lines should not be used to separate columns. Column headings should be brief, with units of measurement in parentheses; all abbreviations should be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings. The table and its legend/footnotes should be understandable without reference to the text.

v) Figure legends
Type figure legends on a separate page. Legends should be concise but self-explanatory – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement. If figures have been reproduced from another source, the Letter to the Editor should state that copyright permission to reproduce the figure has been obtained.

vi) Appendices
These should be placed at the end of the paper, numbered in Roman numerals and referred to in the text. If written by a person other than the author of the main text, the writer’s name should be included below the title.

All illustrations (graphs, line drawings and photographs) are classified as figures. Figures should be numbered using Arabic numerals, and cited in consecutive order in the text. Each figure should be supplied as a separate file, with the figure number incorporated in the file name.

Photographs should be supplied as sharp, glossy, black and white photographic prints and must be unmounted. Individual photographs forming a composite figure should be of equal contrast, to facilitate printing, and should be accurately squared. Where subjects are recognizable, photographs need to be cropped sufficiently to prevent the subject being recognized, or an eye bar used, and written permission to publish must be obtained.

Magnifications should be indicated using a scale bar on the illustration.

Upon submission, each figure should be saved as a separate electronic image of no more than 1MB (e.g. in jpg or bmp format). The name of the file should include the figure number.

Preparation of Electronic Figures for Publication:
Although low quality images are adequate for review purposes, publication requires high quality images to prevent the final product being blurred or fuzzy. Submit EPS (line art) or TIFF (halftone/photographs) files only. MS PowerPoint and Word Graphics are unsuitable for printed pictures. Do not use pixel-oriented programmes. Scans (TIFF only) should have a resolution of 300 dpi (halftone) or 600 to 1200 dpi (line drawings) in relation to the reproduction size (see below). EPS files should be saved with fonts embedded (and with a TIFF preview if possible). For scanned images, the scanning resolution (at final image size) should be as follows to ensure good reproduction: line art: >600 dpi; half-tones (including gel photographs): >300 dpi; figures containing both halftone and line images: >600 dpi.

Advice on figures can be found at Wiley’s guidelines for preparation of figures:

Colour figures
Figures may be reproduced in colour in the journal at the authors’ expense.

Supplementary Information (Online Only)
Supplementary information must be important, additional information that is relevant but not essential or integral to the parent article and which does not appear in the printed and online edition of the journal. Supplementary Information can comprise additional tables, data sets, figures, movie files, audio clips, and other related nonessential multimedia files. Like the manuscript accompanying it, it should be original and not previously published. If previously published it must be submitted with the necessary permissions.

Although the International Journal of Nursing Practice has a word limit that excludes tables there may be occasions where it is appropriate for authors to submit other relevant tables and data as web-based supplementary information. This could include, for example, tables of excluded studies and literature search strategies to supplement systematic reviews, and additional reporting of qualitative findings. Web-based supplementary files should be no more than 20 pages in length, or 5 MB. For full technical details please click here.

Supplementary information files should be referenced explicitly by file name within the body of the paper, e.g. 'See supplementary information file/table/figure 1’. Supplementary information files will not be displayed within the paper. They will be approved by the editor but not reviewed or edited, and will be made available on the International Journal of Nursing Practice website in exactly the same form as originally provided. Supplementary information files can be uploaded alongside main manuscripts during submission to ScholarOne Manuscripts.

Please make sure the file is clearly labelled, and choose ‘supplementary information file’ from the drop down list of file designations.

The National Information Standards Organization (NISO) has prepared best practice guidelines for supplementary materials.


All submissions, including manuscripts, figures and the covering letter should be submitted online at

New users to the site must register by selecting ‘Create new account’ button. NO payments are required for submission. Manuscripts should be uploaded as Word or rich text format (rtf) documents. Each figure should be saved as a separate image file with the figure number incorporated in the file name. For peer review, we recommend that figures are saved as low resolution images of less than 1MB, for ease of transmission, although upon acceptance high resolution files or original images will be required for publication (see Figures section).

Further instructions are available at the submission site. Authors who require assistance should contact the Editorial Assistant (tel: +61 (0)3 9274 3118; fax: 61 (0)3 9274 3390; email:

Submissions should comprise:

  • A cover letter included in the ‘Cover Letter Field’ of the ScholarOne system. The text can be entered directly into the field or uploaded as a file. Papers are accepted for publication in the Journal on the understanding that the content has not been published or submitted for publication elsewhere, and this must be stated in the covering letter. The covering letter must state that all authors have contributed significantly, and that all authors are in agreement with the content of the manuscript. In keeping with the guidelines of the International Committee of Medical Journal Editors, each author’s contribution to the paper must be identified. Authors must also state in the letter that the protocol for the research project has been approved by a suitably constituted Ethics Committee of the institution where the work was undertaken, if appropriate, and that it conforms to the provisions of the Declaration of Helsinki in 1995 (as revised in Edinburgh 2000), available at
  • At least two word-processed files: a title page file and a main text file that includes all parts of the text in the sequence indicated in the section 'Parts of the manuscript', including tables and figure legends but excluding figures which should be supplied separately.
  • The main text file should be prepared doubled-spaced.The top, bottom and side margins should be 25 mm. All pages should be numbered consecutively in the top right-hand corner, beginning with the first page of the main text file.
  • Each figure should be supplied as a separate file, with the figure number incorporated in the file name. For submission, low-resolution figures saved as .jpg or .bmp files should be uploaded, for ease of transmission during the review process. Upon acceptance of the article, high-resolution figures (at least 300 d.p.i.) saved as .eps or .tif files will be required.

Associate your ScholarOne account with your ORCID iD
ORCID iD is a unique and persistent identifier that distinguishes you from every other researcher and connects you and your research activities. We encourage you to register for an ORCID iD and then associate it with your ScholarOne account. Click here to find out how.

Submission of revised papers

When revising your paper, taking into account the reviewers’ and Editor’s feedback, please highlight all changed text using red font. Please do not use tracked changes as they can make papers difficult to follow. To submit revised papers please log into your author centre at and click ‘Create a Revision’.

The submission process is very similar to that for new papers. You will be able to amend any details you wish. At stage 6 (‘File upload’) please delete the files of your original paper, and upload your revised documents.

Please upload an anonymous response to the editor and reviewers' comments which includes a point by point response (listed or in a table) to the feedback given in the decision email, alongside your revised manuscript files.

Review your paper as a PDF, and click ‘submit’.

Please do not submit your revised paper as a new paper, as revised manuscripts are processed differently. If, when you click ‘create a revision’, a message is shown saying that the revision option has expired, please contact the Editorial Assistant at to have it reactivated.


Any appeal against a decision about a paper should be filed within 28 days of notification of the decision. The appeal should be in the form of a letter addressed to the Editor-in-Chief and submitted to the Editorial Assistant at The letter should include clear and concise grounds for the appeal, including specific points of disagreement with the decision. The appeal will then be assessed by members of the editorial team not involved in the original decision, informed by the reviewer assessments and subsequent editorial communications. You will be informed of the outcome of the appeal in writing, normally within 28 days. The decision will be final.


Accepted papers will be passed to Wiley’s production team for publication. The author identified as the formal corresponding author for the paper will receive an email prompting them to login into Wiley’s Author Services, where via the Wiley Author Licensing Service (WALS) they will be asked to complete an electronic license agreement on behalf of all authors on the paper. See COPYRIGHT for more details.

Wiley’s Author Services

Author Services enables authors to track their article through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production. The corresponding author will receive a unique link that enables them to register and have their article automatically added to the system. Please ensure that a complete e-mail address is provided when submitting the manuscript. Visit for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.

The International Journal of Nursing Practice is available at Wiley Online Library. Full-text online articles include reference links to cited articles and external databases, and a full search facility, so that you can find the information you are looking for. Visit to search the articles and register for table of contents and e-mail alerts.


Once the paper has been typeset the corresponding author will receive an e-mail alert containing instructions on how to provide proof corrections to the article. It is therefore essential that a working e-mail address is provided for the corresponding author. Corrections should be returned within 3 days of receipt. Alterations to the text and figures (other than the essential correction of errors) are not accepted at proof stage. If absent, authors should arrange for a colleague to access their email, retrieve the PDF page proof and check and return it to the Publisher on their behalf. Instructions will be sent with the proof, which should be corrected carefully; the responsibility for detecting errors lies with the author.

Early View

The journal offers rapid speed to publication via Wiley’s Early View service. Early View articles are complete full-text articles published online in advance of their publication in a printed issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors' final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. Early View articles are given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before allocation to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article. More information about DOIs can be found at


A PDF reprint of the article will be supplied free of charge to the corresponding author. Additional printed offprints may be ordered online for a fee. Please click on the following link and fill in the necessary details and ensure that you type information in all of the required fields: If you have queries about offprints please e-mail:

Author Marketing Toolkit

The Wiley Author Marketing Toolkit provide authors with support on how to use social media, publicity, conferences, multimedia, email and the web to promote their article.


Authors may choose to publish under the terms of the journal’s standard copyright transfer agreement (CTA), or under open access terms made available via Wiley OnlineOpen.

Standard Copyright Transfer Agreement:
FAQs about the terms and conditions of the standard CTA in place for the journal, including standard terms regarding archiving of the accepted version of the paper, are available at: Copyright Terms and Conditions FAQs.

Note that in signing the journal’s licence agreement authors agree that consent to reproduce figures from another source has been obtained.

Government or company owned work

For government work and company or institution owned work, please see the notes at the bottom of the electronic Copyright Transfer Agreement. For UK government work (Crown Copyright), including NIHR-funded work, this form cannot be completed electronically and should be printed off, signed in the Contributor’s signatures section by the appropriately authorised individual and returned to the Journal production editor by email. Contributors must also submit the appropriate authorisation to publish.

For authors signing the copyright transfer agreement:
If the OnlineOpen option is not selected the corresponding author will be presented with the copyright transfer agreement (CTA) to sign. The terms and conditions of the CTA can be viewed in the Copyright FAQs at:

OnlineOpen – Wiley’s Open Access Option:
OnlineOpen is available to authors of articles who wish to make their article freely available to all on Wiley Online Library under a Creative Commons license. With OnlineOpen, the author, the author's funding agency, or the author's institution pays a fee to ensure that the article is made open access. Authors of OnlineOpen articles are permitted to post the final, published PDF of their article on their personal website, and in an institutional repository or other free public server immediately after publication. All OnlineOpen articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected based on their own merit.

OnlineOpen licenses. Authors choosing OnlineOpen retain copyright in their article and have a choice of publishing under the following Creative Commons License terms: Creative Commons Attribution License (CC BY); Creative Commons Attribution Non-Commercial License (CC BY NC); Creative Commons Attribution Non-Commercial-NoDerivs License (CC BY NC ND). To preview the terms and conditions of these open access agreements please visit the Copyright Terms and Conditions FAQs.

Funder Open Access and Self-Archiving Compliance: Please click here for more information on Wiley’s compliance with specific Funder Open Access and Self Archiving Policies, and click here for more detailed information specifically about Self-Archiving definitions and policies.

Author Material Archive Policy

Authors who require the return of any submitted material that is accepted for publication should inform the Editorial Office after acceptance. If no indication is given that author material should be returned, Wiley will dispose of all hardcopy and electronic material two months after publication.

Note to NIH grantees:
Pursuant to NIH mandate, Wiley-Blackwell will post the accepted version of contributions authored by NIH grant holders to PUBMED Central upon acceptance. This accepted version will be made publicly available 12 months after publication. For further information, see

Author Guidelines updated 22 January 2016